{"id":4587,"date":"2019-11-25T14:55:07","date_gmt":"2019-11-25T13:55:07","guid":{"rendered":"http:\/\/cube-labs.com\/?p=4587"},"modified":"2019-11-25T14:55:07","modified_gmt":"2019-11-25T13:55:07","slug":"chris-hentschel-new-cso-at-cube-labs","status":"publish","type":"post","link":"https:\/\/pazlab.cube-labs.com\/it\/news\/chris-hentschel-new-cso-at-cube-labs\/","title":{"rendered":"Chris Hentschel new CSO at Cube-Labs."},"content":{"rendered":"<p><strong>Chris Hentschel joins, as new Chief Scientific Officer, the Cube Labs team. <\/strong><\/p>\n\n\n\n<p>Cube Labs is operating in the Italian landscape as <strong>the first mover in acceleration of academic R&amp;D focusing on Biotech<\/strong> (oncology, rare diseases, nutraceuticals) and <strong>Medtech<\/strong> (medical devices, e-health, diagnostic).<\/p>\n\n\n\n<p>Chris Hentschel is a molecular biologist and co-founder of The Ulysses Advisory Group. <strong>He has had pioneering and often transformative leadership roles in biosciences in the public sector<\/strong> (MRC Technology Transfer UK),<strong> in the private sector<\/strong> (Celltech, UK; Centocor, USA), <strong>in public-private partnerships<\/strong> (MRC Collaborative Centre, UK; Medicines for Malaria Venture, Switzerland) <strong>and later as a partner and chief scientist at Bio Istanbul.<\/strong><\/p>\n\n\n\n<p>A graduate in biochemistry from King&#8217;s College London, he began his career as an academic researcher at the <strong>National Institute for Medical Research<\/strong> (London, UK).<\/p>\n\n\n\n<p>This led him to a series of research fellowships first in London, then as a European member of molecular biology at the Swiss Federal Institute of Technology in Zurich (ETHZ), and finally as a Fogarty Fellow at the National Cancer Institute (NIH, Bethesda, USA).<\/p>\n\n\n\n<p>All this has allowed Hentschel to <strong>expand his experience and professional background until today<\/strong>, to get to work with a <strong>dynamic reality like Cube-Labs<\/strong> with great growth potential arising from the <strong>use of innovative technologies that bypass the classic scientific solutions<\/strong>. <\/p>\n\n\n\n<p><strong>Hentschel in his carrier closed a large number of deals in licensing out\/in and M&amp;A for more than 5 Billion $.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-image is-style-default\"><figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" src=\"http:\/\/cube-labs.com\/wp-content\/uploads\/2019\/11\/WhatsApp-Image-2019-11-25-at-14.43.15-846x1024.jpeg\" alt=\"\" class=\"wp-image-4588\" width=\"363\" height=\"439\"\/><\/figure><\/div>\n\n\n\n<p><strong>Chris Hentschel \u2192<\/strong> <a rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\" href=\"http:\/\/www.ulyssesadvisorygroup.com\/index.php\/15-the-principals\/chris-hentschel-ph-d\/6-christopher-c-hentschel-ph-d\" target=\"_blank\">http:\/\/www.ulyssesadvisorygroup.com\/index.php\/15-the-principals\/chris-hentschel-ph-d\/6-christopher-c-hentschel-ph-d<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Chris Hentschel joins, as new Chief Scientific Officer, the Cube Labs team. Cube Labs is operating in the Italian landscape as the first mover in acceleration of academic R&amp;D focusing on Biotech (oncology, rare diseases, nutraceuticals) and Medtech (medical devices, e-health, diagnostic). Chris Hentschel is a molecular biologist and co-founder of The Ulysses Advisory Group. [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[48],"tags":[],"class_list":{"0":"post-4587","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-news"},"acf":[],"_links":{"self":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/posts\/4587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/comments?post=4587"}],"version-history":[{"count":0,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/posts\/4587\/revisions"}],"wp:attachment":[{"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/media?parent=4587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/categories?post=4587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pazlab.cube-labs.com\/it\/wp-json\/wp\/v2\/tags?post=4587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}